U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136519) titled 'Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma' on Aug. 01.
Brief Summary: The aim of this study is to evaluate the efficacy, adverse reactions, nutritional status analysis, and quality of life analysis of Toripalimab Plus Induction Chemotherapy Followed by Radiation Therapy Combined with Omega-3 in the treatment of locally advanced nasopharyngeal carcinoma.
Study Start Date: Aug. 22
Study Type: INTERVENTIONAL
Condition:
Nasopharyngeal Carcinoma (NPC)
Intervention:
DRUG: Toripalimab
240mg Q3W
DIETARY_SUPPLEMENT: Omega-3
During radiotherapy, take 6 capsules o...